Clinical Trial

Epicardial Fat Tissue and Cardiometabolic Risk in Russian and Asian Populations

Study acronym: EPIGRAPH
Recruiting
View on ClinicalTrials.gov →
Summary
Visceral obesity is a well-established risk factor for the development of chronic non-communicable diseases (NCDs). Epicardial fat tissue (EFT) is located on the surface of the myocardium and may directly affect cardiac function and contribute to structural and functional remodeling. According to the literature, increased EFT thickness is associated with a wide range of NCDs, disease severity, and prognosis. The aim of this study is to investigate the associations between EFT thickness and clinical and anamnestic parameters, as well as to evaluate the prognostic value of this parameter in patients aged 50-70 years from the Russian Federation, Kazakhstan, Uzbekistan, and Kyrgyzstan.
Trial Details
NCT Number NCT07604610
Lead Sponsor National Medical Research Center for Therapy and Preventive Medicine
Conditions Epicardial Fat Tissue (EFT), Chronic Non-Communicable Diseases (NCDs), Visceral Obesity
Enrollment 500 participants
Start Date 2026-05-04
Primary Completion 2027-03 (estimated)
Study Completion 2028-03 (estimated)
Updated on ClinicalTrials.gov 2026-05-22